BMSEHA15
Haematologica, Vol 95, Issue 3, 367-375 doi:10.3324/haematol.2009.006890
Copyright © 2010 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Smits, K.
Right arrow Articles by Verhasselt, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smits, K.
Right arrow Articles by Verhasselt, B.

Hematopoietic Cells

Rho GTPase Cdc42 is essential for human T-cell development

Kaatje Smits1, Veronica Iannucci1, Veronique Stove1, Peter Van Hauwe2, Evelien Naessens1, Pieter J. Meuwissen1, Kevin K. Ariën1, Mostafa Bentahir1, Jean Plum1, Bruno Verhasselt1

1 Department of Clinical Chemistry, Microbiology and Immunology, Faculty of Medicine and Health Sciences, Ghent University, Gent and
2 University College Ghent, Campus Vesalius, Gent, Belgium

Correspondence: Bruno Verhasselt, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail: bruno.verhasselt{at}ugent.be

Background: Rho GTPases are involved in the regulation of many cell functions, including some related to the actin cytoskeleton. Different Rho GTPases have been shown to be important for T-cell development in mice. However, their role in human T-cell development has not yet been explored.

Design and Methods: We examined the expression and activation of Rho GTPases along different stages of T-cell development in the human thymus. Early stage human thymocytes were transduced with constitutively active and dominant negative mutants of different Rho GTPases to explore their role in human T-cell development, as analyzed in fetal thymus organ cultures. The use of these mutants as well as Rho GTPase-specific inhibitors allowed us to explore the role of GTPases in thymocyte migration.

Results: We found that the expression of several Rho GTPases is differently regulated during successive stages of T-cell development in man, suggesting a specific role in human thymopoiesis. In chimeric fetal thymus organ culture, T-cell development was not or only mildly affected by expression of dominant negative Rac1 and Rac2, but was severely impaired in the presence of dominant negative Cdc42, associated with enhanced apoptosis and reduced proliferation. Kinetic analysis revealed that Cdc42 is necessary in human T-cell development both before and after expression of the pre-T-cell receptor. Using inhibitors and retrovirally transferred mutants of the aforementioned Rho GTPases, we showed that only Rac1 is necessary for migration of different thymocyte subsets, including the early CD34+ fraction, towards stromal cell-derived factor-1{alpha}. Constitutively active mutants of Rac1, Rac2 and Cdc42 all impaired migration towards stromal cell-derived factor-1{alpha} and T-cell development to different degrees.

Conclusions: This is the first report on Rho GTPases in human T-cell development, showing the essential role of Cdc42. Our data suggest that enhanced apoptotic death and reduced proliferation rather than disturbed migration explains the decreased thymopoiesis induced by dominant negative Cdc42.

Key words: lymphopoiesis, Rho GTP-binding proteins, Rac GTP-binding proteins, hematopoietic stem cells, T lymphocytes.